ODDB.org: Open Drug Database

Future Health Pharma GmbH - Rasilez 300 mg, Filmtabletten

Swissmedic Registration	58050	Sequence	02
Product name	Rasilez 300 mg	Description	Filmtabletten
ATC-Classification	C09XA02	ATC-Description	Aliskiren
Introduction of Sequence	29.06.2007

Composition

aliskirenum 300 mg ut aliskireni hemifumaras, cellulosum microcristallinum, crospovidonum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, Überzug: macrogolum 4000, talcum, hypromellosum, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Aliskirenum	300 mg

BAG: Active Agent	Dose
Aliskirenum	300 mg

Inactive agents	Dose	additional_information
(Nigrum)
(Rubrum)
Cellulosum Microcristallinum
Crospovidonum
E 171		color.
E 172		color.
Hypromellosum
Macrogol	4000	Überzug
Magnesii Stearas
Povidonum K	30
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	28 Tablet(s)	25.73	44.40	B		Yes
009	98 Tablet(s)	90.01	114.30	B		Yes

2025	©ywesee GmbH